https://www.prnewswire.com/news-releases/endo-completes-acquisition-of-dava-pharmaceuticals-270220501.html
/PRNewswire/ -- Adds high-margin marketed generics portfolio, robust near-term ANDA pipeline to Endo's existing generics portfolio Ability to leverage Endo's...
endocompletesacquisitiondavapharmaceuticals